Novel FABT-Based Conditioning Regimen with Haploidentical Transplantation for Severe Aplastic Anemia: A prospective, single-center, phase II clinical trial
{{output}}
Background: Haploidentical hematopoietic stem cell transplantation (Haplo-HSCT) serves as an alternative treatment for severe aplastic anemia (SAA) patients lacking a suitable HLA-identical sibling donor. However, its development... ...
